If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Total Voting Rights

28 Nov 2008 07:00

RNS Number : 1242J
Impellam Group plc
28 November 2008
 



Impellam Group plc ("Impellam" or "the Company")

Total Voting Rights

In conformity with rule 5.6.1 of the FSA's Disclosure Rules and Transparency Rules (DTRs), Impellam gives notice that, as at 28 November 2008 the Company's issued share capital consists of 44,998,882 ordinary shares of 1 pence each with voting rights. As the Company does not hold any shares in treasury, the total number of voting rights is equal to the total number of ordinary shares in issue. This figure may be used by shareholders for the purposes of calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

For further information please contact:

Impellam Group plc

Cheryl Jones - Chairman

Tel: 01582 692658

Desmond Doyle - Group Chief Executive Officer 

Andrew Burchall - Group Finance Director

Cenkos Securities plc

(Nominated Adviser and Broker to Impellam)

Nicholas Wells/Beth McKiernan

Tel: 020 7397 8900

Teathers Limited

(Joint Broker to Impellam)

James Wellesley Wesley

Tel: 020 7426 9000

Bell Pottinger Corporate & Financial

Nick Lambert/Sarah Williams

Tel: 020 7861 3232

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRDGMZMVNKGRZM
Date   Source Headline
22nd Dec 201710:12 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSTransaction in Own Shares
18th Dec 20177:00 amRNSShare Purchase Plan
15th Nov 20173:38 pmRNSTrading Statement
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20174:51 pmRNSDirectorate Change
27th Jul 20177:00 amRNSHalf-year Report
28th Jun 201710:49 amRNSResult of AGM
28th Apr 20172:12 pmRNSDirector/PDMR Shareholding
16th Mar 20175:09 pmRNSAnnual Financial Report & Dividend Record Date
9th Mar 20177:00 amRNSPreliminary Results - Unaudited
15th Dec 20167:00 amRNSTrading Update
28th Jul 20167:00 amRNSHalf-year Report
29th Jun 20169:31 amRNSResult of AGM
5th May 20167:00 amRNSQ1 Trading Update
7th Apr 201611:16 amRNSHolding(s) in Company
5th Apr 20163:21 pmRNSIssue of Equity
30th Mar 20162:11 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSDividend Record Date
3rd Mar 20167:00 amRNSPreliminary Results - Unaudited
12th Jan 20168:19 amRNSTrading update and joint broker - replacement
12th Jan 20167:00 amRNSTrading update and appointment of joint broker
14th Dec 201512:15 pmRNSDirector/PDMR Shareholding
11th Dec 20158:01 amRNSTotal Voting Rights
8th Dec 20157:00 amRNSAcquisition and Trading Update
16th Nov 201511:35 amRNSResult of General Meeting
30th Oct 20157:00 amRNSPosting of Circular and Notice of General Meeting
27th Oct 20155:25 pmRNSProposed change in nature of Dividend
2nd Sep 20157:00 amRNSGrant of Options
30th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 20159:00 amRNSPosting of circular
30th Jun 201510:04 amRNSResult of AGM
4th Jun 20157:00 amRNSNotice of AGM and change to dividend timetable
17th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 20154:35 pmRNSIssue of Equity & Director's Shareholding
6th Mar 20159:00 amRNSAnnual Financial Report
3rd Mar 20157:00 amRNSPreliminary Results - Unaudited
16th Jan 20157:00 amRNSPre-Close Trading Update
12th Jan 20157:00 amRNSDirectorate Change
16th Dec 201410:30 amRNSDirectorate Change
13th Nov 20147:30 amRNSHolding(s) in Company
10th Nov 20141:03 pmRNSCompletion of Acquisition and Directorate Change
7th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20148:00 amRNSDirectors' Dealings
4th Nov 20147:10 amRNSPlacing to raise £15 million
4th Nov 20147:00 amRNSAcquisition of Lorien
30th Jul 20147:00 amRNSHalf Yearly Report
18th Jun 20143:44 pmRNSResult of AGM
15th May 20144:00 pmRNSDeath of a Director
7th May 20147:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.